Posted February 06, 2019 04:33:12 A year ago, Merck Pharmaceuticals was forced to shut down a trial of a new anti-disease medication, Merzbacher, after the company admitted to using misleading data in a marketing document.The company also said the drugs could cause side effects, including blood clots, when taken in high doses.But the results were […]

Continue Reading...